Australia · Delayed Price · Currency is AUD Osteopore Statistics
Total Valuation
Osteopore has a market cap or net worth of AUD 2.77 million. The enterprise value is 4.27 million.
| Market Cap | 2.77M |
| Enterprise Value | 4.27M |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Osteopore has 693.59 million shares outstanding. The number of shares has increased by 322.18% in one year.
| Current Share Class | 693.59M |
| Shares Outstanding | 693.59M |
| Shares Change (YoY) | +322.18% |
| Shares Change (QoQ) | +173.25% |
| Owned by Insiders (%) | 16.61% |
| Owned by Institutions (%) | 11.96% |
| Float | 570.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | -1.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.27 |
| Interest Coverage | -11.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -57.24% |
| Return on Invested Capital (ROIC) | -195.04% |
| Return on Capital Employed (ROCE) | 193.54% |
| Weighted Average Cost of Capital (WACC) | 6.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.46 |
Taxes
In the past 12 months, Osteopore has paid 23,235 in taxes.
| Income Tax | 23,235 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.64% in the last 52 weeks. The beta is -0.02, so Osteopore's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -63.64% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 1,565,664 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Osteopore had revenue of AUD 2.93 million and -3.97 million in losses. Loss per share was -0.01.
| Revenue | 2.93M |
| Gross Profit | 2.36M |
| Operating Income | -3.47M |
| Pretax Income | -3.95M |
| Net Income | -3.97M |
| EBITDA | -3.22M |
| EBIT | -3.47M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.28 million in cash and 2.78 million in debt, with a net cash position of -1.49 million or -0.00 per share.
| Cash & Cash Equivalents | 1.28M |
| Total Debt | 2.78M |
| Net Cash | -1.49M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.80M |
| Book Value Per Share | -0.00 |
| Working Capital | -2.00M |
Cash Flow
In the last 12 months, operating cash flow was -2.16 million and capital expenditures -33,484, giving a free cash flow of -2.19 million.
| Operating Cash Flow | -2.16M |
| Capital Expenditures | -33,484 |
| Depreciation & Amortization | 254,513 |
| Net Borrowing | 1.79M |
| Free Cash Flow | -2.19M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 80.64%, with operating and profit margins of -118.62% and -135.81%.
| Gross Margin | 80.64% |
| Operating Margin | -118.62% |
| Pretax Margin | -135.01% |
| Profit Margin | -135.81% |
| EBITDA Margin | -109.92% |
| EBIT Margin | -118.62% |
| FCF Margin | n/a |
Dividends & Yields
Osteopore does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -322.18% |
| Shareholder Yield | -322.18% |
| Earnings Yield | -143.26% |
| FCF Yield | -79.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 23, 2024. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Feb 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
Osteopore has an Altman Z-Score of -12.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.79 |
| Piotroski F-Score | 3 |